Based on the results, the pharmaceutical portfolio outperforms the financial portfolio in terms of the mean and median in a highly significant way for the defensive profile, also keeping this supremacy for the aggressive profile, albeit with lower significance.
← all excerpts
Outperformance of the pharmaceutical sector during the COVID-19 pandemic: Global time-varying screening rule development.
1
—
—